Polycarbophil Alternatives Compared
| Polycarbophil | Docusate | MiraLAX (polyethylene glycol 3350) |
|
|---|
| Polycarbophil | Docusate | MiraLAX (polyethylene glycol 3350) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Over-the-counter
Prescribed for Constipation. Polycarbophil may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Docusate is a stool softener that may be used to treat constipation, but there is a lack of good-quality evidence supporting its use, and most trials have not found it to be effective. It is thought... View more |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Constipation - Acute, Constipation, Bowel Preparation, Irritable Bowel Syndrome. MiraLAX may also be used for purposes not listed in this... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Polycarbophil | More about Docusate | More about MiraLAX (polyethylene glycol 3350) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Polycarbophil has an average rating of 6.7 out of 10 from a total of 4 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Docusate has an average rating of 6.5 out of 10 from a total of 46 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 27% reported a negative effect. |
MiraLAX has an average rating of 7.2 out of 10 from a total of 260 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Polycarbophil prices |
View all Docusate prices |
View all MiraLAX prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Equalactin, Fiber Lax, Fiber Laxative, Fiberall Tablets, FiberCon, Fibernorm, Fibertab | Aqualax, Calcium Stool Softener, Calube, Colace, Colace Micro-Enema, Correctol Softgel Extra Gentle, D-S Caps, DC-240, Dialose, Diocto, Dioctocal, Dioctosoftez, Dioctyn, Dioeze, Dionex, Doc-Q-Lace, Docu, Docu Soft, Docucal, Doculase, Docuprene, Docusil, Docusoft S, DocuSol, DocuSol Kids, DOK, DOS, Doss-Relief, DSS, Dulcolax Stool Softener, Enemeez Mini, Ex-Lax Stool Softener, Fleet Sof-Lax Stool Softener, Genasoft, Kao-Tin, Pedia-Lax Liquid Stool Softener, Pedia-Lax Stool Softener, Phillips Stool Softener, Promolaxin, Silace, Sur-Q-Lax, Surfak View more | Other polyethylene glycol 3350 brands include: ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, PEG3350, Purelax, SunMark ClearLax | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category N
Not classified
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 33 drugs are known to interact with Polycarbophil:
|
A total of 4 drugs are known to interact with Docusate:
|
A total of 221 drugs are known to interact with MiraLAX:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
February 18, 1999 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.